-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VlshGAtfuWJafyd2wrzbiRdZXoFsPl8Wrxh86vXzJ2XgUXzL8qUASqo9tRAPIruv DQbGAFWrwm31Emam0wWZBQ== 0000902664-08-003255.txt : 20081114 0000902664-08-003255.hdr.sgml : 20081114 20081114164600 ACCESSION NUMBER: 0000902664-08-003255 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080930 FILED AS OF DATE: 20081114 DATE AS OF CHANGE: 20081114 EFFECTIVENESS DATE: 20081114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OSS CAPITAL MANAGEMENT CENTRAL INDEX KEY: 0001218321 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10371 FILM NUMBER: 081192286 MAIL ADDRESS: STREET 1: 605 THIRD AVE CITY: NEW YORK STATE: NY ZIP: 10158 13F-HR 1 p08-1593form13fhr.txt O.S.S. CAPITAL MANAGEMENT LP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2008 ---------------------------- Check here if Amendment [ ]; Amendment Number: ----- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: O.S.S. Capital Management LP -------------------------------------------------- Address: 598 Madison Avenue -------------------------------------------------- New York, NY 10022 -------------------------------------------------- Form 13F File Number: 028-10371 --------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Oscar S. Schafer -------------------------------------------------- Title: Senior Managing Member of General Partner -------------------------------------------------- Phone: 212-756-8707 -------------------------------------------------- Signature, Place, and Date of Signing: /s/ Oscar S. Schafer New York, NY 11/14/08 ------------------------ ------------------------------ ---------- [Signature] [City, State] [Date] NOTE: The limited contents of Forms 13F cannot be used as a basis of determining actual or prospective investment performance, and any attempt to use such information may be materially misleading. Report Type (Check only one.): [ x ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ------------- Form 13F Information Table Entry Total: 34 ------------- Form 13F Information Table Value Total: $1,753,085 ------------- (in thousands) List of Other Included Managers: NONE FORM 13F INFORMATION TABLE
NAME OF ISSUER TITLE OF CLASS CUSIP VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ANADARKO PETE CORP COM 032511107 50,038 1,031,500 SH SOLE 1,031,500 0 0 CANADIAN NAT RES LTD COM 136385101 16,430 240,000 SH SOLE 240,000 0 0 COMMSCOPE INC COM 203372107 35,927 1,037,150 SH SOLE 1,037,150 0 0 CRYOLIFE INC COM 228903100 31,666 2,413,585 SH SOLE 2,413,585 0 0 DENBURY RES INC COM NEW 247916208 27,608 1,450,000 SH SOLE 1,450,000 0 0 ENDO PHARMACEUTICALS HLDGS I COM 29264F205 59,560 2,978,000 SH SOLE 2,978,000 0 0 ENZON PHARMACEUTICALS INC COM 293904108 9,108 1,234,200 SH SOLE 1,234,200 0 0 EXTERRAN HLDGS INC COM 30225X103 70,572 2,208,150 SH SOLE 2,208,150 0 0 FIDELITY NATIONAL FINANCIAL CL A 31620R105 103,592 7,047,051 SH SOLE 7,047,051 0 0 FIDELITY NATL INFORMATION SV COM 31620M106 101,104 5,476,926 SH SOLE 5,476,926 0 0 FLAMEL TECHNOLOGIES SA SPONSORED ADR 338488109 45,721 6,246,047 SH SOLE 6,246,047 0 0 FLOWSERVE CORP COM 34354P105 78,664 886,150 SH SOLE 886,150 0 0 GOODRICH CORP COM 382388106 10,400 250,000 SH SOLE 250,000 0 0 LAM RESEARCH CORP COM 512807108 15,150 481,113 SH SOLE 481,113 0 0 LENDER PROCESSING SVCS INC COM 52602E102 194,013 6,356,899 SH SOLE 6,356,899 0 0 MEDIVATION INC COM 58501N101 52,246 1,974,514 SH SOLE 1,974,514 0 0 METAVANTE TECHNOLOGIES INC COM 591407101 28,453 1,477,295 SH SOLE 1,477,295 0 0 NEXEN INC COM 65334H102 18,616 802,000 SH SOLE 802,000 0 0 NOVEN PHARMACEUTICALS INC COM 670009109 40,000 3,424,690 SH SOLE 3,424,690 0 0 PAR PHARMACEUTICAL COS INC COM 69888P106 28,024 2,280,200 SH SOLE 2,280,200 0 0 REGAL ENTMT GROUP CL A 758766109 23,252 1,473,500 SH SOLE 1,473,500 0 0 SALLY BEAUTY HLDGS INC COM 79546E104 83,796 9,743,750 SH SOLE 9,743,750 0 0 SHIRE LIMITED SPONSORED ADR 82481R106 76,868 1,609,800 SH SOLE 1,609,800 0 0 SMART BALANCE INC COM 83169Y108 42,524 6,482,270 SH SOLE 6,482,270 0 0 SOUTHERN UN CO NEW COM 844030106 28,158 1,363,600 SH SOLE 1,363,600 0 0 TALISMAN ENERGY INC COM 87425E103 24,383 1,714,700 SH SOLE 1,714,700 0 0 TIME WARNER INC COM 887317105 141,326 10,780,000 SH SOLE 10,780,000 0 0 TRANSALTA CORP COM 89346D107 49,365 1,836,700 SH SOLE 1,836,700 0 0 TYCO INTL LTD BERMUDA SHS G9143X208 100,004 2,855,625 SH SOLE 2,855,625 0 0 ULURU INC COM 90403T100 11,687 11,687,415 SH SOLE 11,687,415 0 0 WACHOVIA CORP NEW COM 929903102 5,338 1,525,100 SH SOLE 1,525,100 0 0 WESTERN UN CO COM 959802109 30,314 1,228,777 SH SOLE 1,228,777 0 0 WYNDHAM WORLDWIDE CORP COM 98310W108 85,861 5,465,360 SH SOLE 5,465,360 0 0 WYNN RESORTS LTD COM 983134107 33,317 408,100 SH SOLE 408,100 0 0
-----END PRIVACY-ENHANCED MESSAGE-----